Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-26 @ 3:51 AM
NCT ID:
NCT02937818
Group ID:
EG001
Title:
Arm A: Durvalumab + Tremelimumab (Expansion Cohort)
Description:
Participants received durvalumab 1500 mg + tremelimumab 75 mg via intravenous (IV) infusion every 4 weeks (q4w), starting on Week 0, for up to a total of 4 months (4 cycles) followed by durvalumab monotherapy 1500 mg via IV infusion q4w, starting on Week 16 until confirmed PD, or other discontinuation criteria.
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
20
Other Number Affected:
16
Other Number At Risk:
20
Study:
NCT02937818
Results Section:
NCT02937818
Adverse Events Module:
NCT02937818